Pharmicell consists of Biopharmaceutical Business Division and Biochemical Business Division.
Biopharmaceutical Business Division has engaged in stem cell banking based on various know-hows accumulated in the course of drug development of stem cell drug, the core of our business., We also have developed cosmetics containing stem cell culture media extract which is currently on sale.
Biochemical Business Division was newly created by merger in 2012 and its subsequent merger in 2013 of IDB- Chem Co., Ltd,. the specialized company of raw material medicine. We produc flame retardants and raw material medicines such as mPEG, Nucleoside, HDP-tosylate and Vincelactam.